Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric B Suhler

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Ocular Immunology and Inflammation|January 26, 2023
Reduced Dose Methotrexate and Mycophenolate Mofetil in Noninfectious Uveitis: A Sub-Analysis from the First-Line Antimetabolites as Steroid Sparing Therapy (FAST) TrialAmol A Sura, Yuwei Sun, Amit K Reddy, et al.
The British Journal of Ophthalmology|February 5, 2013
Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trialEric B Suhler, Careen Y Lowder, Debra A Goldstein, et al.
Ophthalmology|January 27, 2022
Time to Uveitis Control with Methotrexate and Mycophenolate MofetilAnh D Bui, Christina L Kong, Nicole K Kelly, et al.
Ophthalmology|August 3, 2015
The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious UveitisSrishti Kothari, C Stephen Foster, Maxwell Pistilli, et al.
Journal of Ocular Biology, Diseases, and Informatics|September 14, 2010
Ocular disease in patients with ANCA-positive vasculitisAngela S Watkins, John H Kempen, Dongseok Choi, et al.
Ophthalmic Epidemiology|February 27, 2008
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort StudyJohn H Kempen, Ebenezer Daniel, Sapna Gangaputra, et al.
Ocular Immunology and Inflammation|June 15, 2007
A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's diseaseRonald R Buggage, Grace Levy-Clarke, Hatice N Sen, et al.
American Journal of Ophthalmology|June 23, 2024
Outcomes in Patients With Vogt-Koyanagi-Harada Disease From the First-Line Antimetabolites for Steroid-Sparing Treatment Uveitis TrialNisha R Acharya, Sivakumar R Rathinam, Radhika Thundikandy, et al.
Ocular Immunology and Inflammation|February 7, 2023
Association between Quality of Life and Visual Acuity in a Randomized Clinical Trial of Patients with Uveitis Taking AntimetabolitesAheli Chattopadhyay, S R Rathinam, John A Gonzales, et al.
Ophthalmology|February 10, 2022
Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis TrialEdmund Tsui, Sivakumar R Rathinam, John A Gonzales, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Ocular Immunology and Inflammation|January 26, 2023
Reduced Dose Methotrexate and Mycophenolate Mofetil in Noninfectious Uveitis: A Sub-Analysis from the First-Line Antimetabolites as Steroid Sparing Therapy (FAST) TrialAmol A Sura, Yuwei Sun, Amit K Reddy, et al.
The British Journal of Ophthalmology|February 5, 2013
Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trialEric B Suhler, Careen Y Lowder, Debra A Goldstein, et al.
Ophthalmology|January 27, 2022
Time to Uveitis Control with Methotrexate and Mycophenolate MofetilAnh D Bui, Christina L Kong, Nicole K Kelly, et al.
Ophthalmology|August 3, 2015
The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious UveitisSrishti Kothari, C Stephen Foster, Maxwell Pistilli, et al.
Journal of Ocular Biology, Diseases, and Informatics|September 14, 2010
Ocular disease in patients with ANCA-positive vasculitisAngela S Watkins, John H Kempen, Dongseok Choi, et al.
Ophthalmic Epidemiology|February 27, 2008
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort StudyJohn H Kempen, Ebenezer Daniel, Sapna Gangaputra, et al.
Ocular Immunology and Inflammation|June 15, 2007
A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's diseaseRonald R Buggage, Grace Levy-Clarke, Hatice N Sen, et al.
American Journal of Ophthalmology|June 23, 2024
Outcomes in Patients With Vogt-Koyanagi-Harada Disease From the First-Line Antimetabolites for Steroid-Sparing Treatment Uveitis TrialNisha R Acharya, Sivakumar R Rathinam, Radhika Thundikandy, et al.
Ocular Immunology and Inflammation|February 7, 2023
Association between Quality of Life and Visual Acuity in a Randomized Clinical Trial of Patients with Uveitis Taking AntimetabolitesAheli Chattopadhyay, S R Rathinam, John A Gonzales, et al.
Ophthalmology|February 10, 2022
Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis TrialEdmund Tsui, Sivakumar R Rathinam, John A Gonzales, et al.
Pageof 14